Peer-Reviewed Publication
BMC Infect Dis2026;26(1)February 9, 2026Journal Article
Burden of adverse transplant outcomes in kidney transplant recipients with COVID-19 and invasive fungal infections: a retrospective cohort study.
Lucy X Li1, Jiashu Xue2, Teresa Po-Yu Chiang3,4, Sean X Zhang5, John W Baddley2, Shmuel Shoham2, Daniel C Brennan2, Kieren A Marr2,6,7, Christine M Durand2, Robin K Avery2, William A Werbel2, Nitipong Permpalung2,8
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lli101@jh.edu.
2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
3Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
4Center for Surgical & Transplant Applied Research, New York University Grossman School of Medicine, New York, NY, USA.
5Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
6Elion Therapeutics, Boston, MA, USA.
7Pearl Diagnostics, Baltimore, MD, USA.
8Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Abstract
BACKGROUND: Invasive fungal infections (IFI) are a serious complication in kidney transplant recipients (KTR), leading to increased mortality and allograft failure. Common respiratory viral infections, such as COVID-19, are associated with IFIs, which might compound adverse transplant outcomes. METHODS: This retrospective cohort study examined adult KTRs transplanted at Johns Hopkins from 2012 to…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans